Big biotech, Biotech, Insight journal - Dealtalk, Partnering, Pharma

Vertex seeking partner for its VX-787 influenza candidate

Posted on 05 March 2013

Tags: ,

Vertex Pharmaceuticals showcased the latest results for influenza candidate VX-787 to attract partnering companies.

Vertex Pharmaceuticals announced that treatment with VX-787 in a Phase 2 influenza challenge study resulted in statistically significant improvements in viral and clinical measurements of infection.

VX-787 is an investigational new class of medicine for the treatment of influenza and is designed to directly inhibit replication of the virus.

The study met its primary endpoint, and showed a statistically significant decrease in the amount of virus in nasal secretions (viral shedding) over the seven-day study period.

Based on these data, Vertex will explore collaborative opportunities to support further development of VX-787.

Vertex Pharmaceuticals is a top biotech company, or bigbiotech company, based in Cambridge, MA, USA.

Vertex has more than 2,000 employees around the world, and for three years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences.

Read the full press release at the Vertex website, where you can also contact Vertex for collaboration and partnering enquiries.

Steve Poile

 

Related

Read: more on Vertex Pharmaceuticals company profile, recent partnering, M&A and financing news and articles

Report: Partnering Deals and Alliances with Big Pharma

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Print Friendly, PDF & Email

Leave a Reply